Codd R J, Thomas R, Heard H, Radcliffe A G, Williams G L, Evans M D
Department of Colorectal Surgery, Morriston Hospital, Swansea, UK.
Welsh Cancer Intelligence and Surveillance Unit, Public Health Wales, Cardiff, UK.
Frontline Gastroenterol. 2013 Oct;4(4):302-307. doi: 10.1136/flgastro-2013-100335. Epub 2013 Jul 6.
Population screening for colorectal cancer (CRC) was introduced to Wales in October 2008. The aim of this study was to evaluate the early impact of screening on CRC services.
Prospectively collected data from the Bowel Screening Wales (BSW) programme and the Welsh Bowel Cancer Audit (WBCA) were used to identify all screen-detected (SD) CRC diagnoses in Wales between April 2009 and March 2011. Data from the WBCA were used to calculate surgical outcomes.
444 SD cancers were registered during the study period representing 11% of all CRC diagnoses. There was a 9.9% increase in CRC incidence following the introduction of the BSW. SD patients presented with earlier stage disease; SD Dukes' A 35.1% vs 13.9% symptomatic patients (p<0.001) and SD Dukes' D 7.4% vs 21.8% symptomatic, (p<0.001). There were more colonic cancers among the SD population (p<0.001). The resection rate for SD cancers was 89%, significantly higher than symptomatic cancers (67.7%; p<0.0001). There was variability in the use of polypectomy as a definitive procedure to treat CRC between units. Overall laparoscopic resection was used in 52% of cases but with considerable interunit variability (0-92%).
The introduction of screening has increased the workload of the colorectal multidisciplinary teams in Wales. This has occurred through both an increase in case volume and the identification of more patients with early stage disease. There is considerable interunit variability in the use of techniques of local excision and rates of laparoscopic resection that need to be addressed.
2008年10月,威尔士引入了结直肠癌(CRC)人群筛查。本研究的目的是评估筛查对CRC服务的早期影响。
前瞻性收集来自威尔士肠道筛查(BSW)计划和威尔士肠癌审计(WBCA)的数据,以确定2009年4月至2011年3月期间威尔士所有筛查发现(SD)的CRC诊断。WBCA的数据用于计算手术结果。
在研究期间登记了444例SD癌症,占所有CRC诊断的11%。引入BSW后,CRC发病率增加了9.9%。SD患者的疾病分期更早;SD Dukes'A期为35.1%,有症状患者为13.9%(p<0.001),SD Dukes'D期为7.4%,有症状患者为21.8%(p<0.001)。SD人群中的结肠癌更多(p<0.001)。SD癌症的切除率为89%,显著高于有症状癌症(67.7%;p<0.0001)。各单位在使用息肉切除术作为治疗CRC的确定性手术方面存在差异。总体而言,52%的病例采用了腹腔镜切除术,但各单位之间存在很大差异(0-92%)。
筛查的引入增加了威尔士结直肠多学科团队的工作量。这是通过病例数量的增加和更多早期疾病患者的识别而发生的。在局部切除技术的使用和腹腔镜切除率方面存在相当大的单位间差异,需要加以解决。